2010
DOI: 10.1111/j.1365-2362.2010.02449.x
|View full text |Cite
|
Sign up to set email alerts
|

Circulating endothelial‐coagulative activation markers after smoking cessation: a 12‐month observational study

Abstract: Chronic exposure to cigarette smoke sustains the activation of the endothelial-coagulative system and abstinence may result in the improvement of several endothelial-coagulative abnormalities in regular smokers. This may translate into an overall decline in cardiovascular risk.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
53
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
2

Relationship

3
4

Authors

Journals

citations
Cited by 52 publications
(58 citation statements)
references
References 67 publications
1
53
1
Order By: Relevance
“…Development and progression of HCC is still not a completely known multistage process. Genetic, epigenetic and immunological factors probably contribute to the development of HCC [7,11,13,37,38,50,51,101,297,298] .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Development and progression of HCC is still not a completely known multistage process. Genetic, epigenetic and immunological factors probably contribute to the development of HCC [7,11,13,37,38,50,51,101,297,298] .…”
Section: Discussionmentioning
confidence: 99%
“…As regards HCC prevention, all exposed workers should have HBV vaccination. In addition, campaigns against smoking and alcohol drinking should be organized, providing an explicit warning that these factors may contribute to the development of liver cancer [10][11][12]101] . Development and progression of HCC is still not a completely known multistage process.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The primary HCV infection is completely asym ptomatic in 60%-70% of cases, but in 80% of patients the infection becomes chronic and is characterized by the persistence of the viral genome in the blood for at least 6 mo from the onset of acute infection. In a variable proportion of people carrying the virus, especially in the presence of strong necro-inflammation and/or cofactors of liver damage, the disease can evolve from the condition of chronic hepatitis to cirrhosis and HCC.There are several factors that can change the course, severity and progression of the disease, including age at the time of infection, route of infection, viral load, coinfection with other hepatitis viruses or HIV, alterations of immune status, and the coexistence of other hepatolesive factors such as consumption of alcohol, iron overload, obesity, type 2 diabetes, resistance to insulin and genetic factors [12][13][14] . Chronic HCV infection in about 20% of cases progresses up to hepatic cirrhosis, end-stage liver disease and HCC, generally after 20-30 years from primary infection.…”
mentioning
confidence: 99%
“…Once HCV infection progresses to cirrhosis, there is a 1%-5% annual risk of HCC [12] . The probability that a patient with compensated cirrhosis can evolve towards the decompensated form increases progressively over time.Liver cirrhosis and its complications (portal hypertension and therefore esophageal varices, splenomegaly, ascites, hepatic encephalopathy, spontaneous bacterial peritonitis, hepatorenal syndrome, hepato-pulmonary syndrome and HCC) are burdened with high morbidity and mortality.It is also known that different variables influence the progression of the disease, for which the prognosis changes individually and is very hard to define [12][13][14] . Several studies have concluded that the eradication of HCV infection slows the progression of the disease, improves the survival, and reduces the incidence of liver failure and the risk of developing liver cancer [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28] .…”
mentioning
confidence: 99%